1. Identification of Acer2 as a First Susceptibility Gene for Lithium-Induced Nephrogenic Diabetes Insipidus in Mice
- Author
-
Cungui Mao, Birgitte Mønster Christensen, Ron Korstanje, Alain Doucet, Karolina M. Andralojc, Benjamin E. Low, Roger Sandhoff, Peter M.T. Deen, Michael V. Wiles, Lydie Cheval, Lena K. Ebert, Theun de Groot, Ruben Baumgarten, Radboud university [Nijmegen], Centre de Recherche des Cordeliers (CRC), Université Pierre et Marie Curie - Paris 6 (UPMC)-École pratique des hautes études (EPHE), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Université Paris Diderot - Paris 7 (UPD7)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM), and German Cancer Research Center - Deutsches Krebsforschungszentrum [Heidelberg] (DKFZ)
- Subjects
[SDV]Life Sciences [q-bio] ,lnfectious Diseases and Global Health Radboud Institute for Molecular Life Sciences [Radboudumc 4] ,030232 urology & nephrology ,MESH: Mice, Knockout ,0302 clinical medicine ,Inbred strain ,MESH: Sodium ,MESH: Animals ,Acidosis ,0303 health sciences ,MESH: Dinoprostone ,MESH: Genetic Predisposition to Disease ,MESH: Lithium Chloride ,General Medicine ,water-electrolyte balance ,3. Good health ,Nephrology ,Urine osmolality ,acidosis ,medicine.symptom ,medicine.medical_specialty ,chemistry.chemical_element ,genetics and development ,MESH: Acidosis ,Calcium ,MESH: Mice, Inbred Strains ,MESH: Hypercalcemia ,MESH: Hematocrit ,03 medical and health sciences ,Internal medicine ,medicine ,MESH: Species Specificity ,MESH: Diabetes Insipidus, Nephrogenic ,Adverse effect ,MESH: Kidney Tubules, Collecting ,MESH: Mice ,MESH: Nephrons ,MESH: RNA, Messenger ,030304 developmental biology ,Calcium metabolism ,calcium ,MESH: Alkaline Ceramidase ,business.industry ,medicine.disease ,Nephrogenic diabetes insipidus ,MESH: Acid-Base Equilibrium ,Renal disorders Radboud Institute for Molecular Life Sciences [Radboudumc 11] ,Endocrinology ,chemistry ,MESH: Genome-Wide Association Study ,Diabetes insipidus ,business ,MESH: Female - Abstract
Item does not contain fulltext BACKGROUND: Lithium, mainstay treatment for bipolar disorder, causes nephrogenic diabetes insipidus and hypercalcemia in about 20% and 10% of patients, respectively, and may lead to acidosis. These adverse effects develop in only a subset of patients treated with lithium, suggesting genetic factors play a role. METHODS: To identify susceptibility genes for lithium-induced adverse effects, we performed a genome-wide association study in mice, which develop such effects faster than humans. On day 8 and 10 after assigning female mice from 29 different inbred strains to normal chow or lithium diet (40 mmol/kg), we housed the animals for 48 hours in metabolic cages for urine collection. We also collected blood samples. RESULTS: In 17 strains, lithium treatment significantly elevated urine production, whereas the other 12 strains were not affected. Increased urine production strongly correlated with lower urine osmolality and elevated water intake. Lithium caused acidosis only in one mouse strain, whereas hypercalcemia was found in four strains. Lithium effects on blood pH or ionized calcium did not correlate with effects on urine production. Using genome-wide association analyses, we identified eight gene-containing loci, including a locus containing Acer2, which encodes a ceramidase and is specifically expressed in the collecting duct. Knockout of Acer2 led to increased susceptibility for lithium-induced diabetes insipidus development. CONCLUSIONS: We demonstrate that genome-wide association studies in mice can be used successfully to identify susceptibility genes for development of lithium-induced adverse effects. We identified Acer2 as a first susceptibility gene for lithium-induced diabetes insipidus in mice. 01 december 2019
- Published
- 2019